OrthoPediatrics (KIDS) Reports Q3 Loss, Misses Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of +7.69% and -2.14%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?